ES443011A1 - Benzodiazepine derivatives - Google Patents

Benzodiazepine derivatives

Info

Publication number
ES443011A1
ES443011A1 ES443011A ES443011A ES443011A1 ES 443011 A1 ES443011 A1 ES 443011A1 ES 443011 A ES443011 A ES 443011A ES 443011 A ES443011 A ES 443011A ES 443011 A1 ES443011 A1 ES 443011A1
Authority
ES
Spain
Prior art keywords
formula
hydrogen
see formula
see
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES443011A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10459213&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES443011(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of ES443011A1 publication Critical patent/ES443011A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

A method of preparing a thieno [1,5] -benzodiazepine of the formula: **(See formula)** or an acid addition salt thereof, where R1 and R2 independently represent hydrogen, alkyl, C2-4 alkenyl, C3-6 cycloalkyl, halogen, C1-4 haloalkyl, nitro, amino, C2-4 acylamino, hydroxyl, alkoxy C1-4, C1-4alkylthio or a group of the formula -SO2N (R4) 2 or SO2R4, where R4 is C1-4 alkyl; where (A) R5 is a group of the formula: **(See formula)** where R6 is hydrogen, phenyl optionally substituted by halogen or haloC1-4alkyl C1_4alkyl, cycloalkyl, C3-6, C2_4alkenyl, C1-4alkanoyl, benzyl, C1-4 carboalkoxy or - (CH2) n OX, where n is 2 or 3 and where X is hydrogen or an ester radical, or (B) R5 is a group of the formula: -NH- (CH2) n-Z where n is 2 or 3 and Z is **(See formula)** where R6 is the one defined above, **(See formula)** where R'' and R'''are independently hydrogen or C1-4alkyl or (v) OH and where the group **(See formula)** represents an optionally substituted thiophene ring, fused to the diazepine nucleus; whose procedure consists of: (a) reacting an amine of formula R5-H with a compound of formula (V): **(See formula)** where R1, R2 and R5 are those defined above and where **(See formula)** represents an optionally substituted fused thiophene ring as above and Q represents a radical capable of being cleaved with the hydrogen atom of the amine R5H, (h) if desired, if R5 is **(See formula)** and R6 is C1-4 carboalkoxy, from hydrolysis to the amine where R6 is hydrogen: (c) optionally reacting the product obtained in the previous step of formula (VI): **(See formula)** with an alkylating agent of formula R6X, where R6 is as defined above except for hydrogen and phenyl and where X is a reactive atom. (Machine-translation by Google Translate, not legally binding)
ES443011A 1974-11-26 1975-11-26 Benzodiazepine derivatives Expired ES443011A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51240/74A GB1533235A (en) 1974-11-26 1974-11-26 Benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
ES443011A1 true ES443011A1 (en) 1977-07-01

Family

ID=10459213

Family Applications (1)

Application Number Title Priority Date Filing Date
ES443011A Expired ES443011A1 (en) 1974-11-26 1975-11-26 Benzodiazepine derivatives

Country Status (30)

Country Link
JP (1) JPS6044314B2 (en)
AR (1) AR221203A1 (en)
AT (1) AT351547B (en)
AU (1) AU506340B2 (en)
BE (1) BE835932A (en)
BG (1) BG29573A3 (en)
CA (1) CA1075687A (en)
CH (2) CH613454A5 (en)
CS (1) CS236753B2 (en)
DD (1) DD123343A5 (en)
DE (1) DE2552403C2 (en)
DK (1) DK146887C (en)
ES (1) ES443011A1 (en)
FR (1) FR2292479A1 (en)
GB (1) GB1533235A (en)
HK (1) HK58681A (en)
HU (1) HU172493B (en)
IE (1) IE42564B1 (en)
IL (1) IL48502A (en)
KE (1) KE3163A (en)
MY (1) MY8200149A (en)
NL (1) NL186088C (en)
NZ (1) NZ179335A (en)
PH (2) PH11669A (en)
PL (1) PL100135B1 (en)
RO (1) RO69912A (en)
SE (2) SE421209B (en)
SU (2) SU629879A3 (en)
YU (1) YU298375A (en)
ZA (1) ZA757344B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62792A (en) * 1980-05-07 1985-02-28 Byk Gulden Lomberg Chem Fab Acylated dihydrothienodiazepinone compounds,process for their preparation,and medicaments containing them
GB8819059D0 (en) * 1988-08-11 1988-09-14 Lilly Industries Ltd Benzodiazepine compounds & their use as pharmaceuticals
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
DE69329887T2 (en) * 1992-05-29 2001-05-23 Eli Lilly And Co., Ltd. Thienobenzodiazepine derivatives for the treatment of disorders of the central nervous system
US6043358A (en) 1995-11-01 2000-03-28 Merck & Co., Inc. Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
CA2234641A1 (en) * 1995-11-01 1997-05-09 Merck & Co., Inc. Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
HUP0003718A3 (en) 1997-09-02 2002-11-28 Welfide Corp Fused thiophene derivatives, use thereof and pharmaceutical compositions containing them
PL199016B1 (en) * 2002-06-20 2008-08-29 Adamed Sp Z Oo Method of manufacture of alanzapine, new derivative of n-demethyl olanzapine and method of manufacture of new derivative of n-demethyl olanzapine
SI21270A (en) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Crystal forms of olanzapine and procedures for their preparation
DE10301923B3 (en) * 2003-01-17 2004-09-16 Krka Tovarna Zdravil, D.D. Process and intermediates for the production of olanzapine
AR047461A1 (en) * 2004-01-27 2006-01-18 Synthon Bv TRAINING, PURIFICATION AND USE OF N-FORMILOLANZAPINE
AR048272A1 (en) 2004-03-18 2006-04-12 Lek Pharmaceuticals SYNTHESIS OF 2 METHYL - 4- (4- METHYL -1- PIPERAZINIL) - 10 H- TIENO (2,3-B) (1,5) BENZODIAZEPIN AND ITS SALTS, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND ITS USE IN THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF MENTAL DISEASES.
UA88786C2 (en) * 2004-06-30 2009-11-25 Атерсис, Инк. Substituted azepine derivatives as serotonin receptor modulators
EP2292624A1 (en) 2009-07-20 2011-03-09 LEK Pharmaceuticals d.d. Process for the purification of olanzapine

Also Published As

Publication number Publication date
GB1533235A (en) 1978-11-22
YU298375A (en) 1982-10-31
DE2552403A1 (en) 1976-08-12
AR221203A1 (en) 1981-01-15
SE421209B (en) 1981-12-07
ATA898275A (en) 1979-01-15
NL7513833A (en) 1976-05-31
DE2552403C2 (en) 1986-06-19
SE429045B (en) 1983-08-08
IE42564L (en) 1976-05-26
KE3163A (en) 1981-10-16
AU8685875A (en) 1977-05-26
MY8200149A (en) 1982-12-31
NL186088C (en) 1990-09-17
IL48502A (en) 1980-01-31
CH613454A5 (en) 1979-09-28
SE7812194L (en) 1978-11-27
CS236753B2 (en) 1985-05-15
HU172493B (en) 1978-09-28
FR2292479A1 (en) 1976-06-25
DK146887B (en) 1984-01-30
IE42564B1 (en) 1980-09-10
CH613455A5 (en) 1979-09-28
DK146887C (en) 1984-07-09
PL100135B1 (en) 1978-09-30
RO69912A (en) 1980-08-15
DD123343A5 (en) 1976-12-12
NZ179335A (en) 1978-11-13
AU506340B2 (en) 1979-12-20
BG29573A3 (en) 1980-12-12
NL186088B (en) 1990-04-17
DK524175A (en) 1976-05-27
JPS5176296A (en) 1976-07-01
PH24534A (en) 1990-08-03
HK58681A (en) 1981-12-04
ZA757344B (en) 1976-11-24
PH11669A (en) 1978-05-19
FR2292479B1 (en) 1978-07-28
SU629879A3 (en) 1978-10-25
AT351547B (en) 1979-07-25
IL48502A0 (en) 1976-01-30
JPS6044314B2 (en) 1985-10-02
BE835932A (en) 1976-05-25
SE7513185L (en) 1976-05-27
CA1075687A (en) 1980-04-15
SU626702A3 (en) 1978-09-30

Similar Documents

Publication Publication Date Title
ES443011A1 (en) Benzodiazepine derivatives
ES432131A1 (en) Esters and carbamates of aminoalkanols
TW197421B (en)
ES448408A1 (en) Uncatalyzed aroylation of 1-alkylpyrrole-2-acetic acid derivatives
DE69501487D1 (en) Manufacture of thioamides
PT79118B (en) CEPHALOSPORINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
ES527739A0 (en) A PROCEDURE FOR PREPARING PIRIMIDINE DERIVATIVES
ES423058A1 (en) 3-(isopropyl amino alkoxy)-2-phenyl-isoindolin-1-ones
ES423104A1 (en) Procedure for preparing heterociclic anilides. (Machine-translation by Google Translate, not legally binding)
DE3560027D1 (en) Process for the preparation of o,o'-dithiobenzamides
ES475120A1 (en) Imidazopyridazines and their use as therapeutic agents
MY101938A (en) Benzothiazoline fungicides
ES451209A1 (en) Antispasmodic substituted sulphoximides
ATE94878T1 (en) IMIDAZOBENZODIAZEPINS AND THEIR ACID ADDITION SALTS, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR MANUFACTURE, THEIR USE AS MEDICINAL PRODUCTS AND PREPARATIONS CONTAINING THEM.
ATE29496T1 (en) TETRAHYDRO-BETA-CARBOLINE DERIVATIVES AND PROCESSES FOR THEIR PRODUCTION.
ES480562A1 (en) Bridged catharanthus alkaloid dimers, their preparation and formulations containing them.
ES453121A1 (en) Substituted aminoalkylaminopyridine compounds
ATE27955T1 (en) PROCESSES AND INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 2-SUBSTITUTED 4-ACETYL-IMIDAZOLES.
IE43092L (en) 4-amino-pyridines.
ES455963A1 (en) A procedure for the preparation of imidazo compounds (1,5-a) (1,4). (Machine-translation by Google Translate, not legally binding)
HUT44502A (en) Process for producing 3-amino-dihydropyridine derivatives and pharmaceutical compositions containing them
JPS56115780A (en) Phenoxyalkaneacid derivative substituted by heterocyclic ring containing nitrogen and sulfur, and its preparation
ES483301A1 (en) A procedure for the preparation of benzodiacepine derivatives. (Machine-translation by Google Translate, not legally binding)
ES445474A1 (en) Thienobenzodiazepines
SE8302886D0 (en) INTERMEDIATES FOR PREPARING SUBSTITUTED 1-PIPERAZINE CARBOXAMIDES AND CARBOTHIOAMIDES AND USE THEREOF